{"id":5074,"date":"2015-02-03T14:26:34","date_gmt":"2015-02-03T20:26:34","guid":{"rendered":"http:\/\/news.medill.northwestern.edu\/chicago\/?p=5074"},"modified":"2015-02-03T14:50:54","modified_gmt":"2015-02-03T20:50:54","slug":"abbvie-expenses-yield-loss-stock-falls","status":"publish","type":"post","link":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/","title":{"rendered":"AbbVie expenses yield loss, stock falls"},"content":{"rendered":"

by Jin Wu<\/p>\n

AbbVie Inc.<\/a> (NYSE: ABBV), the Illinois-based biopharmaceutical company separated from Abbott Laboratories<\/a> in 2013, reported lower profits in both the fourth quarter and the full year due to foreign currency volatility and expenses of the terminated acquisition of Shire Plc.<\/a>, a specialty biopharmaceutical company headquartered in Ireland. The stock dropped 4.3 percent.<\/p>\n

For the quarter ended December 31, AbbVie swung to a loss of $810 million, or 51 cents per diluted share, from earnings of $1.13 billion, or 70 cents per diluted share, in the year-earlier quarter. The diluted EPS missed the negative 44 cents consensus estimate.<\/p>\n

\"For<\/a>
For the quarter ended December 31, AbbVie Inc. reported a loss of 51 cents per diluted share. This is the first time AbbVie reported a loss since it was separated from Abbott Laboratories in 2013. (Bloomberg, Jin Wu\/Medill)<\/figcaption><\/figure>\n

However, based on AbbVie\u2019s adjusted measurement, which excluded intangible asset amortization expense and other specified items primarily related to the terminated Shire transaction, the company earned $1.45 billion, or 89 cents per diluted share, up 9.02 percent from $1.33 billion, or 82 cents per diluted share, in the year-earlier quarter, topping the consensus estimate of 86 cents adjusted EPS.<\/p>\n

In the fourth quarter, revenues increased 6.7 percent to $5.45 billion from $5.11 billion.<\/p>\n

For the 2014 fiscal year, AbbVie\u2019s net income dropped 57.03 percent to $1.78 billion from $4.13 billion. Earnings per diluted share decreased to $1.10 from $2.56, missing the consensus estimate of $1.16 per diluted share. Adjusted diluted EPS increased to $3.32 from $3.14, topping the consensus estimate of $3.29.<\/p>\n

\"AbbVie<\/a>
AbbVie Inc.\u2019s earnings per diluted share dropped to $1.10 from $2.56 for the 2014 fiscal year. (Bloomberg, Jin Wu\/Medill)<\/figcaption><\/figure>\n

Full year 2014 revenues were $19.96 billion, up 6.2 percent from $18.79 billion.<\/p>\n

AbbVie\u2019s fourth-quarter revenue growth was driven primarily by the continued strength of Humira<\/a>, an anti-inflammatory drug. Global Humira sales increased 10.6 percent to $3.36 billion.<\/p>\n

However, the company estimated the impact from foreign currency volatility would continue in 2015.<\/p>\n

\u201cIf the recent rates were to remain in effect for the remainder of the year, our sales growth would be roughly 5 percent lower,\u201d said William J. Chase<\/a>, chief financial officer of AbbVie, in a conference call. \u201cGiven our global business structure and programs we have in place to mitigate exchange impacts, the fall-through from currency to the bottom line is much more modest for us. We are comfortable with our 2015 EPS guidance range despite potential currency swings.\u201d<\/p>\n

For 2015, AbbVie expects to post diluted EPS of $3.91 to $4.11 on a reported basis and $4.25 to $4.45 on an adjusted cash basis, which excludes about 34 cents per diluted share of intangible asset amortization expense and other specified items.<\/p>\n

\u201cFor 2015, we expect Humira to once again be an important contributor to our robust performance with mid-teens global operational growth expected,\u201d said AbbVie\u2019s CEO Richard A. Gonzalez<\/a>, in the conference call. \u201cAnother important driver of our performance in 2015 will be our interferon-free HCV therapy Viekira, which has now been approved in the U.S., the EU and a number of other countries around the world.\u201d<\/p>\n

Gonzalez said the company expects an annualized Viekira sales rate of $3 billion by the end of 2015. The company started shipping the drug in late December.<\/p>\n

Damien Conover, analyst at Morningstar Inc.<\/a>, said in a research note: \u201cThe hepatitis C guidance that to close the year with an annualized Viekira sales rate of $3 billion is below expectations. While management tends to offer conservative guidance, the slower uptake is concerning since Merck and Bristol will likely enter the market in early 2016.\u201d<\/p>\n

Although sales of Viekira<\/a> in the fourth quarter were below Morningstar\u2019s expectation, Conover expressed confidence in its future growth. \u201cInsurance contracting is showing accelerating levels of success, with 40 percent of U.S. patients now covered by insurance, which should rapidly drive Viekira sales in 2015,\u201d he wrote.<\/p>\n

The stock closed at $60.4 Friday, down $2.72.<\/p>\n

Photo at top: AbbVie Inc. is one of the main manufacturers of hepatitis C drugs. (AbbVie Inc.)<\/div>\n","protected":false},"excerpt":{"rendered":"

by Jin Wu AbbVie Inc. (NYSE: ABBV), the Illinois-based biopharmaceutical company separated from Abbott Laboratories in 2013, reported lower profits in both the fourth quarter and the full year due to foreign currency volatility and expenses of the terminated acquisition of Shire Plc., a specialty biopharmaceutical company headquartered in Ireland. The stock dropped 4.3 percent. […]<\/p>\n","protected":false},"author":35,"featured_media":5088,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27,243],"tags":[],"class_list":["post-5074","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-winter-2015"],"yoast_head":"\nAbbVie expenses yield loss, stock falls - Medill Reports Chicago<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie expenses yield loss, stock falls - Medill Reports Chicago\" \/>\n<meta property=\"og:description\" content=\"by Jin Wu AbbVie Inc. (NYSE: ABBV), the Illinois-based biopharmaceutical company separated from Abbott Laboratories in 2013, reported lower profits in both the fourth quarter and the full year due to foreign currency volatility and expenses of the terminated acquisition of Shire Plc., a specialty biopharmaceutical company headquartered in Ireland. The stock dropped 4.3 percent. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/\" \/>\n<meta property=\"og:site_name\" content=\"Medill Reports Chicago\" \/>\n<meta property=\"article:published_time\" content=\"2015-02-03T20:26:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-02-03T20:50:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"jinwu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jinwu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/\"},\"author\":{\"name\":\"jinwu\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/#\\\/schema\\\/person\\\/e9e6009c42310cb2583e1d3e6b93e181\"},\"headline\":\"AbbVie expenses yield loss, stock falls\",\"datePublished\":\"2015-02-03T20:26:34+00:00\",\"dateModified\":\"2015-02-03T20:50:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/\"},\"wordCount\":645,\"image\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.amazonaws.com\\\/medill.wordpress.offload\\\/WP%20Media%20Folder%20-%20medill-reports-chicago\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2015\\\/02\\\/abbvie.jpg\",\"articleSection\":[\"Business\",\"Winter 2015\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/\",\"url\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/\",\"name\":\"AbbVie expenses yield loss, stock falls - Medill Reports Chicago\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.amazonaws.com\\\/medill.wordpress.offload\\\/WP%20Media%20Folder%20-%20medill-reports-chicago\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2015\\\/02\\\/abbvie.jpg\",\"datePublished\":\"2015-02-03T20:26:34+00:00\",\"dateModified\":\"2015-02-03T20:50:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/#\\\/schema\\\/person\\\/e9e6009c42310cb2583e1d3e6b93e181\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.amazonaws.com\\\/medill.wordpress.offload\\\/WP%20Media%20Folder%20-%20medill-reports-chicago\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2015\\\/02\\\/abbvie.jpg\",\"contentUrl\":\"https:\\\/\\\/s3.amazonaws.com\\\/medill.wordpress.offload\\\/WP%20Media%20Folder%20-%20medill-reports-chicago\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2015\\\/02\\\/abbvie.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/abbvie-expenses-yield-loss-stock-falls\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie expenses yield loss, stock falls\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/#website\",\"url\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/\",\"name\":\"Medill Reports Chicago\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/#\\\/schema\\\/person\\\/e9e6009c42310cb2583e1d3e6b93e181\",\"name\":\"jinwu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g\",\"caption\":\"jinwu\"},\"url\":\"https:\\\/\\\/news.medill.northwestern.edu\\\/chicago\\\/author\\\/jinwu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbbVie expenses yield loss, stock falls - Medill Reports Chicago","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/","og_locale":"en_US","og_type":"article","og_title":"AbbVie expenses yield loss, stock falls - Medill Reports Chicago","og_description":"by Jin Wu AbbVie Inc. (NYSE: ABBV), the Illinois-based biopharmaceutical company separated from Abbott Laboratories in 2013, reported lower profits in both the fourth quarter and the full year due to foreign currency volatility and expenses of the terminated acquisition of Shire Plc., a specialty biopharmaceutical company headquartered in Ireland. The stock dropped 4.3 percent. […]","og_url":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/","og_site_name":"Medill Reports Chicago","article_published_time":"2015-02-03T20:26:34+00:00","article_modified_time":"2015-02-03T20:50:54+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg","type":"image\/jpeg"}],"author":"jinwu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jinwu","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#article","isPartOf":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/"},"author":{"name":"jinwu","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/#\/schema\/person\/e9e6009c42310cb2583e1d3e6b93e181"},"headline":"AbbVie expenses yield loss, stock falls","datePublished":"2015-02-03T20:26:34+00:00","dateModified":"2015-02-03T20:50:54+00:00","mainEntityOfPage":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/"},"wordCount":645,"image":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg","articleSection":["Business","Winter 2015"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/","url":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/","name":"AbbVie expenses yield loss, stock falls - Medill Reports Chicago","isPartOf":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/#website"},"primaryImageOfPage":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#primaryimage"},"image":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg","datePublished":"2015-02-03T20:26:34+00:00","dateModified":"2015-02-03T20:50:54+00:00","author":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/#\/schema\/person\/e9e6009c42310cb2583e1d3e6b93e181"},"breadcrumb":{"@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#primaryimage","url":"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg","contentUrl":"https:\/\/s3.amazonaws.com\/medill.wordpress.offload\/WP%20Media%20Folder%20-%20medill-reports-chicago\/wp-content\/uploads\/sites\/3\/2015\/02\/abbvie.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/abbvie-expenses-yield-loss-stock-falls\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/news.medill.northwestern.edu\/chicago\/"},{"@type":"ListItem","position":2,"name":"AbbVie expenses yield loss, stock falls"}]},{"@type":"WebSite","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/#website","url":"https:\/\/news.medill.northwestern.edu\/chicago\/","name":"Medill Reports Chicago","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/news.medill.northwestern.edu\/chicago\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/news.medill.northwestern.edu\/chicago\/#\/schema\/person\/e9e6009c42310cb2583e1d3e6b93e181","name":"jinwu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4501a06ad183f305491979206dcdf3afad67571ac813e1af6dda80e3213ebbf3?s=96&d=mm&r=g","caption":"jinwu"},"url":"https:\/\/news.medill.northwestern.edu\/chicago\/author\/jinwu\/"}]}},"_links":{"self":[{"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/posts\/5074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/comments?post=5074"}],"version-history":[{"count":0,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/posts\/5074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/media\/5088"}],"wp:attachment":[{"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/media?parent=5074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/categories?post=5074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.medill.northwestern.edu\/chicago\/wp-json\/wp\/v2\/tags?post=5074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}